Scaparing!
This AIM struggler is getting acquired by a US listed company. While the acquisition price is far below historic highs it looks a good deal for shareholders given the legacy issues with this business. The Chief Executive has certainly benefited handsomely over the years, shareholders less so in recent years. Read on for our usual forthright thoughts.
Scapa Group (LON: SCPA), the diversified healthcare and industrial company which makes advanced woundcare products and industrial bonding solutions, has received a takeover offer from US listed Schweitzer-Maudit International Inc (NYSE:SWM).
Scapa is one of our earlier 'Bonkers Valuation of the week' (not to be confused with our Bonkers Bargains which are considerably more appealing!) which we assessed when the shares were trading at the heady level of 335p. Our assessment here highlighted numerous issues, many of which came…
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Scapa Group
Scaparing!
This AIM struggler is getting acquired by a US listed company. While the acquisition price is…
Vaccine countdown update: 17 Nov (2) - quality is worth the premium
Quality is worth paying a premium for and a company covered here has many of the…
